Thank you for responding, @Diego_HM. Though the pharmaceutical companies evaluated the risk of nitrosamine contamination from several points, the limit has stayed conservatism, 37 ng/day. If CPCA is available, they may provide different control strategies…
As far as I know, there is no document translated into English. I translated it with AI translation, but I am not sure of the correctness.